Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Linda Chen, MPH

Gilead Sciences

Disclosure(s): Gilead Sciences: Employee, Stocks/Bonds; UCB pharmaceuticals: Stocks/Bonds

Poster(s):

1155 - Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET